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Abstract
We provide an update on diagnostic methods for the detection of urogenital schistosomiasis
(UGS) in men and highlight that satisfactory urine-antigen diagnostics for UGS lag much behind
that for intestinal schistosomiasis, where application of a urine-based point-of-care strip assay,
the circulating cathodic antigen (CCA) test, is now advocated. Making specific reference to
male genital schistosomiasis (MGS), we place greater emphasis on parasitological detection
methods and clinical assessment of internal genitalia with ultrasonography. Unlike the advances
made in defining a clinical standard protocol for female genital schistosomiasis, MGS remains
inadequately defined. Whilst urine filtration with microscopic examination for ova of
Schistosoma haematobium is a convenient but error-prone proxy of MGS, we describe a novel
low-cost sampling and direct visualization method for the enumeration of ova in semen.
Using exemplar clinical cases of MGS from our longitudinal cohort study among fishermen
along the shoreline of Lake Malawi, the portfolio of diagnostic needs is appraised including:
the use of symptomatology questionnaires, urine analysis (egg count and CCA measurement),
semen analysis (egg count, circulating anodic antigen measurement and real-time polymerase
chain reaction analysis) alongside clinical assessment with portable ultrasonography.
Introduction
Schistosomiasis remains a prevalent neglected tropical disease (NTD) in low and
middle-income countries of tropical and sub-tropical regions (Colley et al., 2014; McManus
et al., 2018). Each year, some 200 000 deaths occur from complications of this water-borne
infection which is acquired by exposure to contaminated freshwater, often during household
chores, recreational activities or income-generating activities such as fishing or agriculture
(Hotez et al., 2008; Christinet et al., 2016). Following World Health Assembly resolutions
to control schistosomiasis, the World Health Organization (WHO) and various stakeholders
have continued urging countries in endemic areas to intensify morbidity control and strive
towards interruption of schistosome transmission (WHO, 2001, 2012, 2013). A key interven-
tion strategy is preventive chemotherapy by mass drug administration (MDA) with praziquan-
tel (Cesol, Merck), integrated alongside complimentary measures inclusive of improved
sanitation and hygiene, snail control and health education. In addition, an appropriate use
of point-of-care (POC) diagnostic tests in high- and low-disease transmission settings and
individual targeted treatment are vital in schistosomiasis control (Le and Hsieh, 2017).
Diagnosis of urogenital schistosomiasis
First reported by Theodor Bilharz in 1851, infection with schistosome blood flukes gives rise
to schistosomiasis, with Schistosoma haematobium, as recognized today, responsible for
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urogenital schistosomiasis (UGS); here, adult female worms, as
typically found in the vesicle plexus of the bladder, produce copi-
ous amounts of eggs each day that perforate and damage various
internal organs (Gryseels et al., 2006; Rollinson et al., 2013).
Schistosome eggs either cross the bladder wall to be voided in
the urine, or become tissue-trapped in the lower abdominal
organs, inclusive of the internal and external genitalia in both
genders (Ross et al., 2002). These incite local bleeding and induce
fibrotic lesions leading to severe complications across the urogeni-
tal system. Early diagnosis in communities triggers appropriate
praziquantel treatment campaigns and is paramount to maximiz-
ing the public health impact of preventive chemotherapy
(Stothard et al., 2013).
A range of parasitological, immunological and molecular
methods have been used for the detection of UGS (Stothard
et al., 2014). The operational gold standard of diagnosing UGS
is direct microscopy of filtered urine (Peters et al., 1976), which
has been widely used in high-transmission areas to estimate the
morbidity upon enumeration of eggs in 10 ml of urine (i.e. ⩾50
eggs per 10 m). However, it lacks diagnostic sensitivity in light
infection when the number of eggs shed in urine is very few
(counting less than one egg in 10 ml) and repeated urine samples
may need to be inspected. Other less expensive methods that can
complement this test include the use of questionnaires in high-
risk areas for the recognition of macrohaematuria (presence of
red urine), and urine reagent test strips for microhaematuria as
a diagnostic indicator and marker of bladder pathology, although
these suffer from poor rates of sensitivity (<75%) and cannot
detect sub-clinical or acute infections (Stothard et al., 2014; Le
and Hsieh, 2017).
Antibody-based tests such as enzyme-linked immunosorbent
assay (ELISA) for IgG titres against schistosome soluble egg anti-
gen present in human serum have been widely used for diagnosis
(Le and Hsieh, 2017). Serological methods have much higher sen-
sitivities than filtration and microscopy, especially in travellers
originating from non-endemic regions, however they cannot dis-
tinguish active from past infections, nor discriminate between
species of schistosome. Alternative highly sensitive approaches
based on the detection of schistosome glycan antigens in blood
or urine have been developed to diagnose active Schistosoma
infections (Utzinger et al., 2015; Le and Hsieh, 2017), which are
described below. Nucleic acid amplification tests (NAAT) have
increasingly been used as highly sensitive and specific diagnostic
tools, utilizing several clinical specimens (i.e. stool, urine or tissue
biopsy) in diagnosing the infection (Utzinger et al., 2015).
Currently NAAT are not widely available, owing to the need for
skilled personnel, laboratory equipment and infrastructure
which make roll out, especially in endemic areas, limited.
Newer approaches based on loop-mediated isothermal amplifica-
tion, POC magnetic bio-capture probes and microfluidic devices
are being developed for resource poor settings (Minetti et al.,
2016; Candido et al., 2018; Poulton and Webster, 2018).
Glycobiology of schistosome antigens and their
applications
A number of different schistosome antigens are excreted and
secreted into the human circulation, namely cercarial antigens,
gut-associated antigens from living juvenile and adult worms and
antigens secreted from eggs (van Lieshout et al., 2000). Most of
the described circulating genus specific antigens in humans are
from gut-associated tissues of feeding worms, namely circulating
cathodic antigen (CCA) and circulating anodic antigen (CAA).
Both CCA and CAA, see Fig. 1A, are detectable in the host’s
serum as well as in urine although relative concentrations can differ
and these are thought to have immunomodulating effects within
the parasitized host (Dam and Deelder, 1996; van Dam et al.,
1996; van Diepen et al., 2012; Hokke and van Diepen, 2017).
Glycoproteins containing CCA are produced by the gut
epithelium of schistosomes presumably for its protection and
are regurgitated into the human bloodstream upon digestion of
the blood meal as worms have a blind-end gut. The structure of
these positively-charged antigens consists of multiple trisacchar-
ide units (Lewis-X) containing fructose, galactose and N-acetyl-
galactosamine, Fig. 1. In addition, CCA epitopes are also present
on Schistosoma egg secretions. They also evoke high titres of spe-
cific IgM/IgG antibodies, which may be responsible for the mild-
moderate neutropenia during schistosome infection (van Dam
et al., 1996).
Making use of CCA, POC urine-based lateral-flow assays have
been developed since the late 90s and have been commercially
available since 2002 in the form of reagent dipsticks or cassettes,
with carbon- or gold-labelled monoclonal antibodies and inter-
preted visually (van Dam et al., 2004; Le and Hsieh, 2017).
Detectable CCA-levels typically correlate with active schistosome
infection, which become undetectable after successful praziquan-
tel treatment. However, upon comparison with intestinal schisto-
somiasis (caused by Schistosoma mansoni) these tests perform
poorly for UGS see Table 1, hence combining it with urine filtra-
tion is needed, and can help with simultaneous detection of
co-infected cases (i.e. S. haematobium and S. mansoni). Since
the first use of point-of-care circulating cathodic antigen
(POC-CCA) tests, they have been subject to many evaluations
of their performance, with the WHO now endorsing these tests
as appropriate for estimating prevalence thresholds for intestinal
schistosomiasis to guide preventive chemotherapy (Colley et al.,
2017; Bärenbold et al., 2018). Current developments in POC test-
ing include a prototype dual antigen cassette with both CCA and
CAA strips included, enabling the detection and discrimination of
intestinal and UGS simultaneously see Fig. 1B (see https://freebily.
eu/about/).
The alternative CAA antigens are also gut-associated glycopro-
teins but are negatively charged. The structure of CAA is made up
of carbohydrate chains which consist of multiple disaccharide
units containing N-acetyl-galactosamine and glucuronic acid
(Fig. 1). It binds to the collagen-like stalk of first complement
component C1q, probably preventing host complement from
attacking the schistosome gut (van Dam et al., 1993). CAA is
also present in urine or serum of actively infected people as
shown by monoclonal antibody-based antigen detection ELISA’s
and more recently up-converting phosphor-lateral flow assay
(UCP-LF CAA) (Corstjens et al., 2008). This assay has shown
to be more sensitive and specific especially in low-transmission
areas but is unable to differentiate between urogenital and intes-
tinal schistosomiasis (Corstjens et al., 2015; Knopp et al., 2015).
The UCP-LF-CAA test therefore has future application in the
general monitoring of schistosomiasis as disease control pro-
grammes move towards interruption of transmission or endgame
scenarios (Corstjens et al., 2017; Stothard et al., 2017).
Focus on male genital schistosomiasis
Despite being known as urogenital disease, genital manifestations
of S. haematobium infections in both genders have been underre-
ported, ignored and less frequently diagnosed. Unlike the increas-
ing awareness of female genital schistosomiasis (FGS) within
endemic populations (Christinet et al., 2016), in part due to the
wider health-seeking behaviour of women, an appreciation of male
genital schistosomiasis (MGS) remains limited. MGS describes a
specific manifestation associated with the presence of schistosome
eggs in seminal fluids and genital tissues in addition to various
pathologies in the male genital system (WHO, 2018). Following
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its first description by Madden, (1911), several research studies and
case reports have described the condition, unknowingly present in
endemic areas, causing genital and pelvic pain, haemospermia,
abnormal ejaculates, infertility among other abnormalities, also
detectable by radiological methods (Vilana et al., 1997; Squire
and Stothard, 2014; Kayuni et al., 2019). Furthermore, studies
have shown increased levels of inflammatory cells and immuno-
logical mediators in semen harbouring Schistosoma eggs which
necessitate HIV attachment and replication, and changes in sem-
inal viral loads among co-infected males, highlighting the plausible
link of increased risk of HIV transmission from co-infected males
to their sexual partners (Leutscher et al., 2000, 2005, 2008b; Stecher
et al., 2015; Midzi et al., 2017).
Substantial progress has been made in developing a gold
standard technique for a definite FGS diagnosis, namely colpos-
copy in gynaecological clinics (WHO, 2015) often with genital tis-
sue biopsy for histopathology in the hospital laboratory.
Conversely, MGS remains largely undefined, an orphan within
disease syndromic triage (Kayuni et al., 2019). At present,
semen microscopy is considered as a standard technique for diag-
nosing active MGS infection and assessing its severity, since the
schistosome eggs are directly visualized. Urine filtration has
been used as diagnostic proxy markers in the presence of MGS
symptoms; however, there have been reports of seminal schisto-
some eggs in urine negative patients (Schwartz et al., 2002; van
Delft et al., 2007). In addition, genital tissue biopsy and ultrason-
ography can be applied as diagnostic tools relevant in diagnosing
MGS through observation of pathologies associated with the
disease in the absence of other genital diseases, which have suc-
cessfully been studied and reported (Leutscher et al., 2008b).
In light of the above, we describe the research study protocol of
our longitudinal cohort MGS study among fishermen (with and
without HIV infection) along the south shoreline of Lake
Malawi in the Mangochi District. Preliminary results of the
study at baseline are presented together with two exemplar clinical
case reports, illustrating the diagnostic challenges for MGS.
Longitudinal cohort study of MGS along southern Lake
Malawi shoreline
Malawi is one of the South Eastern African countries where both S.
haematobium and S. mansoni are prevalent and highly focal around
most water bodies (Teesdale and Chitsulo, 1985; Makaula et al.,
2014). The shoreline of Lake Malawi, the third largest lake in
Africa, is endemic for urogenital schistosomiasis, with a high preva-
lence of urine-ova patent S. haematobium infections (Madsen et al.,
2011; Stauffer et al., 2014). More recently, with the discovery of
Biomphalaria pfeifferi there is also emergence of autochthonous
transmission of intestinal schistosomiasis (Alharbi et al., 2019).
More broadly, children, women, farmers and fishermen are at
greater risk of the disease due to more frequent water contact.
The prevalence of HIV in Malawi is considered high (10.6%),
especially in this lakeshore region (11.8%), despite the control
efforts contributing to reducing the incidence and mortality
(NAC, 2015; UNAIDS, 2016). Despite the wide awareness for
the significant burden of UGS in the area, MGS typically remains
Fig. 1. (A) Schematic outline of the chemical and polymeric glycan structures of the two most common schistosome glycoproteins (CCA and CAA) using in rapid
urine-antigen detection dipsticks. (B) An illustration of future developments in POC diagnostics with a prototype dual antigen urine-dipstick detecting each antigen
separately (LHS CCA, RHS CAA). Having a dual design could detect and differentiate urogenital and intestinal schistosomiasis co-infection simultaneously, however,
this prototype has inadequate sensitivity for the detection of urine-CAA and needs reformulation.
Table 1. Sensitivity and specificity of urine POC-CCA tests to diagnose S. haematobium infection, in comparison to urine filtration and microscopy as a routine
standard test
Source Prevalence (%) Sensitivity (%) (95% CI) Specificity (%) (95% CI)
Stothard et al. (2009) 31 9 (2–21) 98 (93–100)
Ayele et al. (2008) Moderate 52 (42–62) 64 (54–73)
Midzi et al. (2009) Moderate 79 (70–86) 44 (36–52)
Ashton et al. (2011) Moderate 37 (26–49) 79 (72–84)
Obeng et al. (2008)* Not stated 41 (not stated) 91 (not stated)
El-Ghareeb et al. (2016)* 5 88 (not stated) 96 (not stated)
Sanneh et al. (2017)* 23 48 (not stated) 76 (not stated)
Rubaba et al. (2018)* 40 68 (not stated) 46 (not stated)
Range – 9–88 44–98
Data adapted from Ochodo et al. (2015), where intensities of infection are classed as ‘moderate’. Additional sources marked by ‘*’. Where data is missing this is marked as ‘not stated’.
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undiagnosed and underreported among men. With no informa-
tion about the burden of MGS on the south shoreline of Lake
Malawi in Mangochi District, our research study set out to deter-
mine the current prevalence and morbidity of MGS among local
fishermen on the shoreline and the potential risk of raised HIV
transmission through viral load shedding in semen.
Study methodology
Study area, population and sampling
The research study was conducted among fishermen living in fish-
ing communities (villages) identified and selected along the south
shoreline of Lake Malawi in Mangochi District from October
2017 to December 2018. Mangochi is the largest district in the
southern region of Malawi, covering 6729 km2 of land with at
least 1.1 million people (NSO, 2018). The district has a tropical con-
tinental climate with a longer dry season of cold weather from May
to August and hot weather from September to November, and a
relatively shorter wet season from December to April (NSO,
2011). Most fishermen in the area live in specific fishing villages,
closer to the lake to carry out their routine fishing related activities.
This was a longitudinal cohort study, comprising baseline sur-
veys of MGS among fishermen and follow-up studies after prazi-
quantel treatment, conducted in villages and nearby health
centres. Fishermen aged ⩾18 years willing to provide written
informed consent were eligible to participate in the study. Using
the estimated 20% prevalence of S. haematobium in adults from
previous studies and assuming 10% having MGS, a minimum
sample size of 275 fishermen (adjusted for assumed 10% loss to
follow-up), was planned to be randomly selected for the study
to measure the current prevalence of MGS and subsequent
follow-up studies (Kirkwood and Sterne, 2006; CDC, 2014).
Data collection and analysis
The following are the data collection methods and analyses that
were used in the study:
Individual questionnaires
After briefing about the study and obtaining written informed
consent, fishermen were recruited in their communities and inter-
viewed with individual questionnaires, collecting information on
demographic, health, hygiene, sanitation and socio-economic
characteristics. This information assessed their knowledge, per-
ceptions, attitudes and practices on MGS and HIV. The question-
naires were developed from standardized questions administered
elsewhere in a similar study (Ukwandu and Nmorsi, 2004). The
questionnaires were piloted on the first 10 participants to assess
the reliability of the questions. After the questionnaire interviews,
the participants were invited to the nearby health facility to sub-
mit urine, semen and for ultrasonography examination.
Parasitological analyses
At the health facility, they were provided with a clean sample con-
tainer to submit urine, between 10 am and 2 pm for filtration to
examine for schistosome eggs (confirming UGS). Semen was sub-
mitted in a clear, transparent, self-sealing plastic bag, see Fig. 2,
after abstaining from coitus for two days to examine for MGS,
defined in the study as the presence of schistosome eggs in semen.
Urine analysis – filtration: Urine was analysed immediately for
macrohaematuria by visual inspection using a urine colour card,
and then for microhaematuria, leukocytes and proteinuria using
reagent strips (Siemens multistix 10G) and scores were recorded
in the following categories: negative, trace, +, ++ and +++. The
POC-CCA test was conducted on the urine to assess for possible
intestinal infection by S. mansoni, following manufacturer’s
instructions (Rapid Medical Diagnostics, South Africa; batch no.
171103130) and as described previously (van Dam et al., 2004).
Urine was measured and recorded accordingly, before conducting
filtration following approved standard guidelines (WHO, 1991;
Cheesbrough, 2009).
The entire volume of urine was filtered through a disinfected fil-
ter containing a clean polycarbonate membrane with 20 µm pores
to trap all S. haematobium eggs in the sample. The membrane was
removed, placed on a standard glass slide and examined under a
microscope. Iodine was added to visualize the eggs distinctly. The
number of eggs was calculated by first, dividing the total eggs
observed by the total volume filtered and then multiplying by 10.
The resultant egg count was recorded per 10 ml of urine. Highest
infection intensity for UGS was defined as egg count of ⩾50 eggs
per 10 ml urine as widely described (Cheesbrough, 2009).
Seminal microscopic analysis: After submission, the bag with
semen was placed at room temperature on a clean bench surface
to allow the semen to liquefy. Thereafter, the semen was pushed
gently to one corner of the clear plastic bag. Then the bag was
heat-sealed to evenly concentrate the semen for easy visualization
during microscopy. The direct examination of the semen bag was
conducted under a microscope to check for schistosome eggs and
the presence of leukocytes (WHO, 2010), thereafter the results
were recorded as per ml of ejaculate.
Afterwards, the semen was measured and centrifuged at
3000 rpm for 5 min to collect the seminal plasma. The sediment
was re-dissolved in 0.5 ml normal saline for wet mount inspection
using 2–3 drops and placed on a slide with a coverslip for micros-
copy, followed by recording of the results. Thereafter, 0.5 ml of etha-
nol was added to the remaining sediment for preservation and stored
together with the seminal plasma at −80 °C in preparation for ship-
ment to the United Kingdom for the real-time polymerase chain
reaction (PCR) analysis of Schistosoma genus DNA and HIV viral
load for those participants on antiretroviral therapy (ART).
UCP-LF CAA seminal analysis: A trichloroacetic acid (TCA)
extraction was performed on the seminal plasma following stand-
ard methods used for serum with an equal volume of 4% w/v
TCA (Corstjens et al., 2008). Small volume extraction (50 µl sem-
inal plasma with 50 µL TCA) in microfuge tubes resulted in a
clear supernatant after centrifugation (5 min, 13 000 rpm).
UCP-LF CAA analysis was performed according to standard meth-
ods with 20 µl of the clear supernatant, with a cut-off threshold of
10 pg ml−1. High-volume extraction (0.5 ml seminal plasma with
0.5 ml TCA and a cut-off threshold of 1 pg ml−1) required
extended centrifugation time (30 min) before a clear supernatant
was obtained; the resulting pellet was not rigid. Amicon 10 kDa
centrifugal filtration devices (Merck Millipore) were used to con-
centrate 0.5 ml of the clear supernatant targeting concentration
to 20 µl following standard methods used for serum undergoing
centrifugation for 30 min at 13 000 rpm (Corstjens et al., 2014).
Schistosoma DNA real-time PCR analysis: The ethanol pre-
served semen sediment was defrosted and centrifuged for 1
minute at 10 000 rpm. The ethanol layer was removed, and the
pellet washed twice with 1 ml of phosphate buffered saline
(PBS). The pellet was suspended in 0.4 ml of PBS containing
2% polyvinylpolypyrrolidone (Sigma, Steinheim, Germany). The
suspension was heated for 10 min at 95 °c and stored frozen over-
night at −20 °C. DNA was extracted using the QIA symphony
DSP virus/pathogen midi kit and pathogen complex 400 protocol
of the QIA symphony Sample Processing (SP) system (Qiagen,
Hilden, Germany). In each sample, a fixed amount of Phocine
Herpes Virus 1 (PhHV-1) was added within the isolation lysis
buffer, to serve as an internal control for the isolation procedure
and to monitor the inhibition of the real-time PCR. The
Schistosoma genus-specific real-time PCR was performed using
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primers and probes as described previously (Obeng et al., 2008;
Kenguele et al., 2014).
Ultrasonography examination
Participants were briefed on the transabdominal and scrotal ultra-
sonography procedures to be conducted on them using a portable
Chison Q5 ultrasound scanner with 3.5 MHz probe supplied by
Mount International United Services Ltd, Gloucester, United
Kingdom. Participants were asked to present with a full bladder,
before the procedure to increase the visualization and validity of
the images. The participant was positioned supine on the examin-
ation couch with the scanner set up on their right side. Whenever
possible, room lightning was turned off to maximize screen visibility.
The scanning procedure investigated the appearance, size and
abnormalities of the following key pelvic and genital organs: urinary
bladder (shape, thickness, calcifications, masses, polyps), seminal
vesicles (symmetry, thickness, nodules, echogenicity) and scrotum
(tests, epididymis: nodules, masses, calcifications, hydroceles),
according to evidence-based recommendations (Vilana et al., 1997;
WHO, 2000; Martino et al., 2014). The observations made during
the procedure and degree of visualization were recorded accordingly.
All clips and images were stored on the device before transfer-
ring to the external hard drive for further analyses. A sample of
15% of the scan images were randomly selected and re-read by
specialist radiologist for quality control, who conducted training
of the study scanning personnel. All participants were notified
of pathological findings that day, and further appropriate investi-
gations and management were organized in accordance with
standard clinical practice. Thereafter, praziquantel treatment at
40 mg kg−1 as a single dose was offered along with an invitation
to follow-up studies after 1-, 3-, 6- and 12-months.
Data analyses
All the information collected during the study was screened and
quality-controlled before entry into Microsoft Excel and SSPS
computer packages. Screening for errors and cleaning were con-
ducted, before commencing statistical analyses to present the
results of the study.
Ethical considerations: Ethical clearance for the study was
granted by both the Liverpool School of Tropical Medicine
Research Ethics Committee (LSTM REC Approval number:
17-018) and the National Health Sciences Research Committee
of Malawi (NHSRC Approval number: 1805). Utmost privacy
and confidentiality were maintained in the study and where
necessary, the information was anonymized to protect the identity
of the participant. Participants were informed of their right to
opt-out at any stage of the study if they wish to do so. No disrup-
tion was caused to their normal daily activities or seeking other
services at any health facility. Since this was a test-to-treat
study, participants were offered praziquantel treatment at the
end of the visit before inviting them to the next follow-up study.
Preliminary baseline results of the study
A total of 376 fishermen were recruited at baseline into the study
who were interviewed with questionnaires, 56 were HIV infected
and receiving ART. The participants came from 39 villages
located in two Traditional Authorities (T/A) of Mponda and
Nankumba, along the shoreline within the study area. The median
age of the participants was 30.0 years with a range of 18.0 to 70.0
years (interquartile range [IQR]: 13.0) and their duration of stay
in the fishing village ranged from 1 month to 70 years (median:
20.0 years; IQR: 24.3). The mean weight of the participants was
59.1 kg (range: 43.0–85.0 kg; 95% C.I.: 58.1–59.9).
Out of the total recruited participants, only 210 submitted
urine after questionnaires (55.9%) and 114 submitted semen
(30.3%). Urine reagent dipstick showed that most of the urine
was observed to be negative for leukocytes (82.4%), blood
(72.9%), protein (63.8%) and glucose (100%). After urine filtra-
tion, 36 participants (17.1%) had S. haematobium eggs in urine
(UGS), their mean egg count was 14.8 eggs per 10 ml and ranged
from 0.1 to 186.0 eggs (median: 0.9, IQR: 5.4). The total urine
volumes ranged from 10 ml to 240 ml and only three participants
had the highest infection intensity (92, 137.8 and 186 eggs). Eight
(3.8%) had a positive POC-CCA test, suggestive of possible
S. mansoni intestinal schistosomiasis infection.
For those who submitted semen, 12 (10.4%) had S. haemato-
bium eggs in semen (MGS). The median egg count was 2.9 per
ml of ejaculate, ranging from 0.4 to 30.0 eggs and the volume
of semen ranged from 0.1 to 4.5 mL (median: 1.4 ml). The
semen bag method identified eight participants (66.7%) whose
median egg count was 0.8, while the centrifuge method identified
nine participants (75.0%) with a median of 2.9 eggs, and only five
participants (41.7%) were observed to have MGS by both methods
simultaneously. Eight participants (66.7%) with MGS had no eggs
in urine, the median volume of which was 60.0 ml (range: 10–
90 ml). Upon interview on the use of the collection bag, 71.0%
(n = 51) men preferred the use of a bag method vs the use of
the screw top sample container.
Transabdominal and scrotal ultrasonography was conducted
on 125 participants at baseline and 25 abnormalities were noted
in the gential organs. For UCP-LF CAA analyses of the first 14
semen samples, only five samples were noted to generate a super-
natant that could be concentrated using the Amicon concentra-
tion devices. Further analyses are underway for the remaining
samples collected in the study.
The real-time PCR conducted on 65 semen samples revealed
that 18 (26.5%) were positive (Ct-value range: 18.6–36.6) of
Fig. 2. (A) pictorial methodology of visualization of schistosome ova in semen with a clean, non-sterile transparent plastic bag. (A) Semen is concentrated to one
corner; (B) the bag is heat sealed to trap the liquid; (C) the bag is placed on microscope stage and inspected at ×40 or ×100 magnification; (D) an egg of S. hae-
matobium with miracidium inside.
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which seven had no eggs in semen or urine while only six parti-
cipants had eggs in urine only. For those participants with eggs in
semen but negative on the PCR could explain an old infection
with dead eggs which were migrating in the genital organs and
then released into ejaculatory ducts and seminal fluid. Using
the seminal schistosome PCR as a reference test for MGS diagno-
sis in comparison with semen microscopy, the latter had a sensi-
tivity of 25.3% and a specificity of 70.6%, which is substantially
lower than using urine filtration as a proxy for MGS diagnosis.
Interestingly, the positive predictive value of semen microscopy
was 40.6% while the negative predictive value was 77.3%, which
highlights the further need to develop more sensitive and specific
diagnostic tests to diagnose MGS.
Here we present two exemplar clinical case reports, summar-
ized in Table 2, demonstrating the outcomes and potential chal-
lenges of different diagnostic tests for MGS used in the
longitudinal study.
Case 1
This concerns a 24-year-old HIV-negative fisherman recruited
into the study, 48.0 kg body weight, had been fishing in the
lake for 14 years. He was experiencing occasional spontaneous
pain in the scrotal region for over a month. He had no previous
history of receiving praziquantel during annual MDA campaigns.
After describing his symptoms during questionnaire interview, he
was requested to submit urine and semen samples for parasito-
logical diagnosis of egg-patent S. haematobium infections upon
microscopy.
His 70 ml mid-morning urine was normal in colour, and
the urine reagent strip showed a trace of leukocytes and protein,
the presence of microhaematuria (+++ blood score), while the
POC-CCA test was negative. After filtration, 150 S. haematobium
eggs were detected on microscopy (21.4 eggs per 10 ml of urine).
He submitted 2 ml of semen in which 5 eggs were observed by the
bag method and 13 eggs after centrifugation (6.5 eggs per ml of
ejaculate), however, no leukocytes were observed.
A CAA concentration of 5 pg ml−1 was found in the seminal
plasma on UCP-LF CAA analysis, using the high-volume extrac-
tion procedure. Analysis of DNA extracted from the harvested
semen sediment registered a strong positive output upon real-time
PCR (Ct-value: 26.6). The results of the egg count and real-time
PCR at baseline and follow-ups are shown in Fig. 3.
Transabdominal and scrotal ultrasonography showed a thick-
ened bladder wall (⩾11 mm) and asymmetrically enlarged sem-
inal vesicles (⩾15 mm). Case 1 was treated with praziquantel
tablets and examined after 1 month and 3 months, where no
schistosome eggs were detected in semen on both occasions.
The real-time PCR on the semen sediment was negative at 1
month but became positive again at 3 months, the Ct-value was
30.8. A total of 11 and 187 schistosome eggs were observed in
his urine at 1- and 3-months respectively (2.4 and 19.7 eggs per
10 ml of urine), with normal findings on ultrasonography.
Case 2
A 26-year-old HIV-negative fisherman recruited into the study,
59.7 kg body weight, had been fishing in the lake one day in a
week for 11 years. He didn’t report any symptoms or illness in
the preceding months or receiving praziquantel during annual
MDA campaigns.
He submitted 35 ml mid-morning urine, which was normal
in colour, and the urine reagent strip showed a trace of protein,
no leukocytes or blood, and the POC-CCA test was positive. No
schistosome eggs were detected on urine filtration nor in his
2.5 ml ejaculate, which had no leukocytes. The real-time PCR
analysis of his semen was negative, transabdominal and scrotal
ultrasonography examination were normal and he was then given
praziquantel treatment. Follow-up at 1-, 3-, 6- and 12-months
showed negative POC-CCA results, no schistosome eggs in urine
or semen, negative real-time PCR and normal ultrasonography
examinations, except a seminal plasma CAA concentration of
1 pg ml−1 on UCP-LF CAA analysis at 6-months, Trace on
POC-CCA and positive real-time PCR of 31.2 on his semen at
12-months.
On the detection of MGS
To our knowledge, this is a first longitudinal cohort research study
and case description of MGS among local fishermen living along
south shoreline of Lake Malawi, a schistosomiasis-endemic region
in the South Eastern part of Africa. Previous studies have focussed
on travellers and expatriates visiting the lake for recreation and
sports. In this endemic setting of Malawi, it is clear that MGS
remains an unrecognized, undiagnosed and underreported illness
among fishermen, despite the more obvious burden of urogenital
schistosomiasis, and we intend for our longitudinal cohort study
to stimulate growing research interest into this condition. Our
Case 1 presented symptoms of MGS previously described in the lit-
erature, resulting from granulomata and associated pathologies
caused by schistosome eggs during their migration and entrapment
through the walls of internal genital organs before being released in
semen, which is pathognomonic of MGS. However, these symp-
toms are commonly mistaken for sexually transmitted infections,
which result in poor diagnosis and management of this treatable
and preventable condition. Praziquantel was generously donated
and distributed to over 89 million people in 2016 through MDA
campaigns although the focus is upon treatment of school-aged
children rather than fishermen (Leutscher et al., 2008a;
Yirenya-Tawiah, Ackumey and Bosompem, 2016; WHO, 2018).
Our cases showed positive results on the UCP-LF CAA ana-
lysis on semen which was performed for the first time in its devel-
opment, hence highlighting the need to optimize the semen
sample concentration technique to allow better detection of
CAA concentrations below 10 pg ml−1. Our case illustrated a
downward trend in egg count after praziquantel treatment at
1-month as well as a negative real-time PCR result, showing clear-
ance of eggs in semen and a putative cure of S. haematobium
infection. This demonstrates that praziquantel appears effective
at the standard dose for MGS treatment, though repeated or
increased doses could be beneficial in cases of heavy infestation
and to counter reinfection (Schwartz et al., 2002), as was seen
in this case. It is worthy to note that at 3 months his urine egg-
count increased together registering a positive real-time PCR
result indicative of a newly acquired infection. To mitigate
re-infection, other strategies such as public health education on
avoidance of high-risk bathing areas, earlier diagnosis and
stepped-up treatment of regularly patently infected people are
needed, especially to regress any progressive morbidity.
Of particular interest is the only positive POC-CCA test in case
2 while all the other diagnostic tests were negative for schistosom-
iasis. This points towards the strong possibility of intestinal schis-
tosomiasis caused by S. mansoni, as was recently discovered
during the course of our longitudinal study (Alharbi et al.,
2019), which redefines the epidemiology of the disease along
the shoreline. The negative POC-CCA result on follow up studies
after praziquantel may further allude to the fact that this infection
was cleared, owing to satisfactory cure rates, previously reported
(Knopp et al., 2013). Definitive results of this case could
arise from further additional diagnostic tests for intestinal schisto-
somiasis and possible schistosome hybrids recently reported in
the area (Webster et al., 2019).
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Table 2. Summary of the clinical cases from the longitudinal cohort research study on MGS among local fishermen along south shoreline of Lake Malawi
Study time-point Parameter Case 1 Case 2
Baseline Symptoms/diseases experienced Scrotal pain No
Previous MDA No No
Urine
Volume (ml) 70 35
Appearance Clear Clear
Reagent dipstick Trace (L, P)
Positive + + + (B)
Trace (P)
Negative (L, B)
POC-CCA Negative Positive
Filtration (eggs per 10 ml) 21.4 0
Semen
Volume (ml) 2.0 2.5
Semen bag (eggs per ml) 2.5 0
Centrifuge (eggs per ml) 6.5 0
UCP-LF CAA (pg ml−1) 5 0
Real-time PCR (Ct value) 26.6 Negative
1-month Follow up Urine
Volume (ml) 45 100
Appearance Clear Clear
Reagent dipstick Positive + + + (L, P)
Negative (P)
Negative (L, B, P)
POC-CCA Negative Negative
Filtration (eggs per 10 ml) 2.4 0
Semen
Volume (ml) 2.5 0.5
Semen bag (eggs ml−1) 0 0
Centrifuge (eggs ml−1) 0 0
UCP-LF CAA (pg ml−1) N/A 0
Real-time PCR (Ct value) Negative Negative
3-months Follow up Urine
Volume (ml) 95 100
Appearance Clear Clear
Reagent dipstick Positive + + (B), + (P), trace (L) Negative (L, B, P)
POC-CCA Negative Negative
Filtration (eggs per 10 ml) 19.7 0
Semen
Volume (ml) 2.6 2.0
Semen bag (eggs per ml) 0 0
Centrifuge (eggs per ml) 0 0
UCP-LF CAA (pg ml−1) N/A 0
Real-time PCR (Ct value) 28.8 Negative
6-months Follow up Urine
Volume (ml) N/D 100
Appearance N/D Clear
Reagent dipstick N/D Negative (L, B, P)
POC-CCA N/D Negative
Filtration (eggs per 10 ml) N/D 0
(Continued )
Parasitology 7
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0031182019000969
Downloaded from https://www.cambridge.org/core. Liverpool School Of Tropical Medicine, on 24 Sep 2019 at 16:07:38, subject to the Cambridge Core terms of use, available at
Chronic pathologies in seminal vesicles, vas deferens, testes
and prostrate alongside the urinary bladder such as calcifica-
tions, hyper-echogenicity, organ enlargements and among
others can be observed on ultrasonography (Vilana et al.,
1997; Ramarakoto et al., 2008). This provided key morbidity fea-
tures aiding the MGS diagnosis and management, although this
procedure is seldom available in most rural health facilities in
Malawi. Our case 1 displayed similar MGS abnormalities in
such organs described in previous publications (Corachan
et al., 1994; Vilana et al., 1997), and showed some resolution
after praziquantel therapy. Where such services are available,
appropriate usage of such services could further aid in MGS
management and avoid unnecessary invasive procedures which
continue to be implored and reported.
Apart from ultrasonography, diagnosis of MGS using a gold
standard technique of semen examination remains a substantive
challenge among medical professionals as it requires the cumber-
some task of semen collection using sterile specimen containers
or non-spermicidal condoms which are costly and unavailable
in endemic areas including Malawi (WHO, 2010; Kipandula
and Lampiao, 2015). In addition, most facilities have poorly
equipped laboratories, with limited-trained personnel to prepare
and examine semen, hence the design of our research study to
use a low-cost, clear self-sealing plastic bag to quickly and easily
examine the semen by direct microscopy can improve opportun-
ities for the diagnosis of MGS in resource poor settings.
The plastic bag is a readily available commodity used for various
activities in households, workplaces and health facilities and is more
affordable (costs 5 cents) than the sterile containerornon-spermicidal
condom (75 and 30 cents, respectively). Our Case 1 showed similar
results between the bagmethod and the standardmethod of centrifu-
gation. In addition, the preference for using the bag in comparison
with the screw top sample container by participants, suggest the
need for further validation of thismethod to determine its applicabil-
ity in clinical practice, especially in limited-resource settings.
The real-time PCR on the harvested semen showed an increase
in the prevalence of MGS (data not shown) which highlights the
need to develop more sensitive and specific diagnostic tests to
diagnose MGS. This is especially important since the current low-
cost standard technique misses a substantial number of indivi-
duals at high-risk of the infection. Although urine filtration is
used as a proxy for MGS diagnosis, its lower sensitivity in indivi-
duals with light infections and also in low-transmission areas,
emphasizes the need to improve the diagnostic platform for MGS.
What outlook for MGS diagnostics?
Urogenital schistosomiasis remains a prevalent NTD in low- and
middle-income tropical countries, particularly in sub-Saharan
Table 2. (Continued.)
Study time-point Parameter Case 1 Case 2
Semen
Volume (ml) N/D 0.8
Semen bag (eggsper ml) N/D 0
Centrifuge (eggsper ml) N/D 0
UCP-LF CAA (pg ml−1) N/D 1
Real-time PCR (Ct value) N/D Negative
12-months Follow up Urine
Volume (ml) N/D 100
Appearance N/D Clear
Reagent dipstick N/D Trace (L), negative (B, P)
POC-CCA N/D Trace
Filtration (eggs per 10 ml) N/D 0
Semen
Volume (ml) N/D 1.1
Semen bag (eggs per ml) N/D 0
Centrifuge (eggs per ml) N/D 0
UCP-LF CAA (pg ml−1) N/D N/A
Real-time PCR (Ct value) N/D 31.2
Urine reagent dipstick test result: L, leukocytes; B, blood; P, protein; N/A, result not available, test currently underway; N/D, participant not available, test not done.
Fig. 3. A line graph of the clinical Case 1 in the longitudinal cohort study showing
results of S. haematobium egg counts in urine (per 10 ml) and semen (per ml);
and Ct-values for real-time PCR analysis of semen at baseline, 1- and 3-month
follow-up studies.
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Africa. As a consequence of MDA, the sensitivities of current urine-
diagnostic tools will further reduce and pose a future challenge in the
detection of lighter infections linked with clinical disease. MGS is an
important but ignored complication of UGS, and there is as of yet
no single diagnostic criteria entirely satisfactory. Indeed, greater
effort should be made to improve specific POC diagnostics, to com-
plement and monitor the progress of MDA programmes and inte-
grated control strategies. We now therefore call for an all-inclusive
diagnostic algorithm for MGS to be developed that accurately iden-
tifies infected men with delivery of best treatment.
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